Invitrogen™ SARS Envelope Protein Synthetic Peptide

Ref.: BL-RE-176026Manufacturer ref.: PEP-0261 50 μg
€149.00 excl. VAT

SARS Envelope Synthetic Peptide, PEP-0261, from Invitrogen.

Species
Virus
Purification method
Purified
Common name
SARS Envelope Protein
Concentration
200 μg/mL
Content and storage
-20°C
Brand
Invitrogen

SARS Envelope Synthetic Peptide, PEP-0261, from Invitrogen.

SARS Envelope Synthetic Peptide, PEP-0261, from Invitrogen.

A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

Species

Species: Virus.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15246479
Specifications
SpeciesVirus
Purification methodPurified
Common nameSARS Envelope Protein
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0261
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.